Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) EPS (Weighted Average and Diluted) (2019 - 2025)

Inspire Medical Systems' EPS (Weighted Average and Diluted) history spans 7 years, with the latest figure at $4.57 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 297.39% year-over-year to $4.57; the TTM value through Dec 2025 reached $4.89, up 182.66%, while the annual FY2025 figure was $4.89, 179.43% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $4.57 at Inspire Medical Systems, up from $0.34 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $4.57 in Q4 2025 and bottomed at -$0.61 in Q1 2022.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.2 (2025), against an average of $0.14.
  • The largest annual shift saw EPS (Weighted Average and Diluted) surged 306.9% in 2024 before it tumbled 137.5% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.08 in 2021, then soared by 262.5% to $0.13 in 2022, then surged by 292.31% to $0.51 in 2023, then skyrocketed by 125.49% to $1.15 in 2024, then surged by 297.39% to $4.57 in 2025.
  • Per Business Quant, the three most recent readings for INSP's EPS (Weighted Average and Diluted) are $4.57 (Q4 2025), $0.34 (Q3 2025), and -$0.12 (Q2 2025).